Media briefing on COVID-19 - 22/02/2021
Date:
22/02/2021
00:00:24
FC Hello, everybody. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Monday 22nd February. The virtual press conference today will include a special guest joining to discuss COVID-19 vaccine research, development and roll-out in conjunction with the COVID vaccine development strategy and implemen...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Access to Essential Medicines and Health Technologies, Health Consortia, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Health Personnel, Immunization Programs/organization & administration, Vaccine Potency, Health Equity, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Press conference Dr Tedros with German Minister for Development Cooperation following visit
Date:
29/03/2021
Full press conference, without interpretation, with WHO Director-General Dr Tedros and Dr Gerd Müller, Federal Minister for Economic Cooperation and Development of Germany held in Geneva, Switzerland on 29 March 2021
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Germany/epidemiology, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Health Consortia, Healthcare Financing, Risk Groups, Equity in Access to Health Services, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 19/03/2021
Date:
19/03/2021
00:00:00
CL Hello, good day wherever you're listening to us today. It's Friday, 15th March [sic] 2021. Apologies for the delay. We had some urgent last-minute changes I hope you can all accommodate. Thank you. My name is Christian Lindmeier and I'm welcoming you to today's COVID-19 press conference with a special focus on the equitable vaccine roll-out in cities.
We have simultaneous interpretati...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Americas/epidemiology, Health Consortia, Health Equity, Risk Groups, Viral Vaccines/adverse effects, Healthcare Financing, COVID-19, Covax, Ghebreyesus, Tedros Adhanom
Vacinas contra a COVID-19 e o mecanismo COVAX
Date:
18/02/2021
Tire suas dúvidas sobre as vacinas contra a COVID-19 e o mecanismo COVAX.
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Immunization Programs/organization & administration, Health Consortia, Universal Access to Health Care Services, Risk Groups, COVID-19, Covax
Pregunte al experto sobre las vacunas contra COVI-D19 - 18/02/2021
Date:
18/02/2021
Pregunte al experto sobre las vacunas contra COVID-19.
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Immunization Programs/organization & administration, Health Consortia, Universal Access to Health Care Services, Risk Groups, COVID-19, Covax
Ask the expert: COVAX & COVID-19 vaccines in the Americas. What you need to know.
Date:
18/02/2021
Ask the expert: COVAX & COVID-19 Vaccines in the Americas. What you need to know.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Immunization Programs/organization & administration, Risk Groups, Health Consortia, Health Services Accessibility, COVID-19, Covax
